Hirano, Yuki http://orcid.org/0000-0002-3976-2278
Kaneko, Hidehiro
Konishi, Takaaki
Itoh, Hidetaka
Matsuda, Satoru
Kawakubo, Hirofumi
Uda, Kazuaki
Matsui, Hiroki
Fushimi, Kiyohide
Daiko, Hiroyuki
Itano, Osamu
Yasunaga, Hideo
Kitagawa, Yuko
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (20AA2005, 21AA2007)
Ministry of Education, Culture, Sports, Science and Technology (20H03907)
Article History
Received: 23 March 2022
Accepted: 12 July 2022
First Online: 12 August 2022
Disclosure
: Yuko Kitagawa has received grants from Chugai Pharmaceutical Co. Ltd, Taiho Pharmaceutical Co. Ltd, Yakult Honsha Co. Ltd, Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co. Ltd, Ono Pharmaceutical Co. Ltd, Tsumura & Co., Kaken Pharmaceutical Co. Ltd, Dainippon Sumitomo Pharma Co. Ltd, EA Pharma Co. Ltd, Eisai Co. Ltd, Otsuka Pharmaceutical Factory Inc., Medicon Inc., Kyowa Hakko Kirin Co. Ltd, Takeda Pharmaceutical Co. Ltd, Toyama Chemical Co. Ltd, Astellas Pharma Inc., Teijin Pharma Limited, Nihon Pharmaceutical Co. Ltd, and Nippon Covidien Inc., as well as lecture fees from Chugai Pharmaceutical Co. Ltd, Taiho Pharmaceutical Co. Ltd, Asahi Kasei Pharma Co. Ltd, Otsuka Pharmaceutical Factory Inc., Ono Pharmaceutical Co. Ltd, Shionogi & Co. Ltd, AstraZeneca K.K., Nippon Covidien Inc., Ethicon Inc., Bristol-Myers Squibb K.K., and Olympus Co. Outside the submitted work. Yuki Hirano, Hidehiro Kaneko, Takaaki Konishi, Hidetaka Itoh, Satoru Matsuda, Hirofumi Kawakubo, Kazuaki Uda, Hiroki Matsui, Kiyohide Fushimi, Hiroyuki Daiko, Osamu Itano, and Hideo Yasunaga have no disclosures to report.